novartis - dofaq.co
Novartis i miljardaffär om onkologibolag
Life Science Sweden - 06 Feb 2024
Novartis i miljardaffär om onkologibolag ...
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
PeptiDream Expands Peptide Discovery Collaboration With Novartis
Contract Pharma - 30 Apr 2024
PeptiDream Expands Peptide Discovery Collaboration With Novartis ...
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
Business Wire - 30 Apr 2024
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis ...
Stock Watch: Novartis And The Changing Face Of Big Pharma
Scrip - 30 Apr 2024
Stock Watch: Novartis And The Changing Face Of Big Pharma ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
Fierce Pharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ...
Medicines for Malaria Venture - 24 Apr 2024
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ... ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
Novartis reports 25% increase in net income in Q1 2024
Pharmaceutical Technology - 24 Apr 2024
Novartis reports 25% increase in net income in Q1 2024 ...
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs
CNBC - 23 Apr 2024
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs ...
Morphosys says Novartis takeover progressing as planned for H1 2024
XM - 29 Apr 2024
Morphosys says Novartis takeover progressing as planned for H1 2024 ...
Novartis in Society Integrated Report
Novartis - 31 Jan 2024
Novartis in Society Integrated Report ...
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair
Fierce Pharma - 23 Apr 2024
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair ...
Research disease areas
Novartis - 08 Feb 2024
Research disease areas ...
Animal Research
Novartis - 31 Jan 2024
Animal Research ...
Community exploration and learning lab (CELL)
Novartis - 08 Feb 2024
Community exploration and learning lab (CELL) ...